Effects of ospemifene on vaginal epithelium of post-menopausal women.

about

Tissue selective estrogen complex (TSEC): a review.

P2860

Q53837780-D8691D71-97D7-4791-88E7-0B82171C83D4

P2860

Effects of ospemifene on vaginal epithelium of post-menopausal women.

Item

http://www.wikidata.org/entity/Q50611000

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Effects of ospemifene on vaginal epithelium of post-menopausal women.

@en

Effects of ospemifene on vaginal epithelium of post-menopausal women.

@nl

type

Item

label

Effects of ospemifene on vaginal epithelium of post-menopausal women.

@en

Effects of ospemifene on vaginal epithelium of post-menopausal women.

@nl

prefLabel

Effects of ospemifene on vaginal epithelium of post-menopausal women.

@en

Effects of ospemifene on vaginal epithelium of post-menopausal women.

@nl

P1476

Effects of ospemifene on vaginal epithelium of post-menopausal women.

@en

P2093

Maria Cristina Meriggiola

http://www.w3.org/2001/XMLSchema#string

Maurizio Baldassarre

http://www.w3.org/2001/XMLSchema#string

Renato Seracchioli

http://www.w3.org/2001/XMLSchema#string

Stefania Alvisi

http://www.w3.org/2001/XMLSchema#string

P2860

Vulvovaginal atrophy.

Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women: results from a pivotal phase 3 study.

Effects of ospemifene, a novel SERM, on hormones, genital tract, climacteric symptoms, and quality of life in postmenopausal women: a double-blind, randomized trial.

Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy.

Vaginal effects of ospemifene in the ovariectomized rat preclinical model of menopause.

Female sexual function improved with ospemifene in postmenopausal women with vulvar and vaginal atrophy: results of a randomized, placebo-controlled trial.

The clinical relevance of the effect of ospemifene on symptoms of vulvar and vaginal atrophy

Effect of ospemifene on moderate or severe symptoms of vulvar and vaginal atrophy

Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey.

Ospemifene 12-month safety and efficacy in postmenopausal women with vulvar and vaginal atrophy.

P304

946-950

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/09513590.2017.1332589

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Valentina Martelli

Giulia Gava

P577

2017-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28562130

http://www.w3.org/2001/XMLSchema#string

Effects of ospemifene on vaginal epithelium of post-menopausal women.

about

P2860

P2860

Effects of ospemifene on vaginal epithelium of post-menopausal women.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698